Trial
NCT05259085
Study of ALXN2050 in Participants With Hepatic Impairment
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Alexion Pharmaceuticals, Inc.
Collaborators
—
Condition
Impaired Hepatic Function
Intervention
ALXN2050
Why stopped
Sponsor decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-19